APOB and type 2 diabetes mellitus: In contrast, studies of statin monotherapy show significantly larger magnitude reductions in LDL-C and non-HDL-C versus apoB in a wide variety of patient populations, including those with T2DM and hypertriglyceridemia [19, 28].